ClinicalTrials.gov
public full text
Public Domain
Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19
This Clinical Trial evaluates nasal administration of Dexamethasone as an adjuvant treatment strategy for non-critically ill hospitalized participants with SARS CoV-2 infection.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Topical Antibacterial Agents for Prevention of COVID-19#914490
- Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICU#896352
- The Efficacy of Oral Antiseptics Against COVID-19#811924
- Impact of Steroids on Inflammatory Response in Covid-19#856612
- Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation#856920
Record · ID 880903
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive